Stay updated on Faricimab in Neovascular AMD Clinical Trial

Sign up to get notified when there's something new on the Faricimab in Neovascular AMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Faricimab in Neovascular AMD Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Administrative updates to the study page, including the last update posted date and minor text edits in the Study Overview and Study Record. These changes do not affect the study's design, eligibility criteria, outcomes, or results.
    Difference
    0.2%
    Check dated 2025-11-03T13:53:44.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Major update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.
    Difference
    0.9%
    Check dated 2025-10-06T04:27:53.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Upgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.
    Difference
    0.0%
    Check dated 2025-09-29T00:59:14.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The update primarily localizes the location label to 'México' (instead of 'Mexico') while preserving the rest of the address; the page revision is bumped to v3.0.2. A non-critical navigation element 'Back to Top' was removed.
    Difference
    0.1%
    Check dated 2025-09-14T18:44:47.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.1%
    Check dated 2025-09-07T13:11:25.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of various facility names and locations across multiple countries, while also removing several previously listed locations and related topics. Notably, the names of drugs such as faricimab and aflibercept have been retained, indicating a focus on specific treatments.
    Difference
    2%
    Check dated 2025-08-31T05:46:44.000Z thumbnail image

Stay in the know with updates to Faricimab in Neovascular AMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Faricimab in Neovascular AMD Clinical Trial page.